IDEXX Laboratories, Inc.

IDXX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$275$294$243$216
Dep. & Amort.-$104$70$34$34
Deferred Tax-$10$6$4$5
Stock-Based Comp.-$44$29$15$14
Change in WC$225-$164-$61-$9
Other Non-Cash$62-$50$3$2
Operating Cash Flow$402$186$238$262
Investing Activities
PP&E Inv.-$31-$34-$30-$29
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$14$0$0-$11
Investing Cash Flow-$45-$34-$30-$40
Financing Activities
Debt Repay.$0$156$70$75
Stock Issued-$25$17$7$13
Stock Repurch.-$240-$338-$401-$246
Dividends Paid$0$0$0$0
Other Fin. Act.-$49-$1-$6-$75
Financing Cash Flow-$313-$166-$330-$233
Forex Effect-$1$14-$2-$10
Net Chg. in Cash$44$1-$124-$20
Supplemental Information
Beg. Cash$165$164$288$309
End Cash$208$165$164$288
Free Cash Flow$371$152$208$223
IDEXX Laboratories, Inc. (IDXX) Financial Statements & Key Stats | AlphaPilot